Phase I clinical trials are designed to identify an appropriate dose for experimentation in phase II and III studies. I present the results from a simulation study to evaluate the performance of nine phase I designs involving the standard design, the two-stage modified Storer's design, the two-stage
A phase i clinical trial of didemnin B
โ Scribed by James A. Stewart; Jane B. Low; John D. Roberts; Alton Blow
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 448 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective: Preclinical evidence indicates that gene transfer to the dorsal root ganglion using replicationโdefective herpes simplex virus (HSV)โbased vectors can reduce painโrelated behavior in animal models of pain. This clinical trial was carried out to assess the safety and explo
This note is a response to a recent paper by Korn et al. in which two phase I trial designs were compared, the designs in question being the standard design and the CRM design. The authors concluded that: (i) CRM designs will take longer to complete than standard designs; and (ii) CRM designs are le
Part I\*: Countries, Diseases, Clinical trial phases, Routes of administration ## Countries Countries where clinical trials are being performed or have been approved Gene therapy trials have now been initiated on all ยฎve continents but the large majority of trials are being performed in the USA